Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The recruitment status on the study page is updated to 'No longer looking for participants', indicating enrollment is closed. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was reformatted for consistency.
    Difference
    0.4%
    Check dated 2026-06-12T16:41:44.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a system update to the study record metadata without altering the study content.
    Difference
    0.1%
    Check dated 2026-06-05T17:28:57.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4, signaling a newer version of the study record page. This appears to be a metadata update rather than a substantive change to the trial details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-15T06:48:43.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page revision identifier was incremented from v3.5.2 to v3.5.3, reflecting a site/version update rather than a change to the trial study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:48.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:37:33.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was rolled out, replacing the previous v3.4.3 release. The update appears to be a routine site version upgrade with no visible changes to the study details or functionality on this page.
    Difference
    0.1%
    Check dated 2026-03-19T06:14:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.